Clinical trial
Smartphone Based Automated-Directly Observed Treatment Improves Adherence and SVR to Fixed-Dose Elbasvir and Grazoprevir in PWIDs: A Randomized Control Trial
NCT03127358 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Smartphone Based Automated-Directly Observed Treatment Improves Adherence and SVR to Fixed-Dose Elbasvir and Grazoprevir in PWIDs: A Randomized Control Trial
- Lead sponsor
- Albert Einstein College of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 14, 2017
- Completion date
- February 6, 2019
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c, medication adherence